Grégoire Wuerzner

Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100)

Juerg Nussberger, Grégoire Wuerzner, C. Jensen et al. · Hypertension · 2002 · 407 citations

May Measurement Month 2017: an analysis of blood pressure screening results worldwide

Thomas Beaney, Aletta E. Schutte, Maciej Tomaszewski et al. · The Lancet Global Health · 2018 · 331 citations · Full text

Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability

George S. Stergiou, Ramakrishna Mukkamala, Alberto Avolio et al. · Journal of Hypertension · 2022 · 178 citations

Safety and immunogenicity of a chimpanzee adenovirus-vectored Ebola vaccine in healthy adults: a randomised, double-blind, placebo-controlled, dose-finding, phase 1/2a study

Olga De Santis, R Audran, Emilie Pothin et al. · The Lancet Infectious Diseases · 2015 · 151 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7

Efficacy and safety of aldosterone synthase inhibition with and without empagliflozin for chronic kidney disease: a randomised, controlled, phase 2 trial

Katherine R. Tuttle, Sibylle J. Hauske, María Eugênia Fernandes Canziani et al. · The Lancet · 2023 · 151 citations · Full text

Hypertension, Renal Function, Renal Disease +10